Liu Xiaoguang, Moussa Charbel
Translational Neurotherapeutics Program, Laboratory for Dementia and Parkinsonism, Department of Neurology, Georgetown University Medical Center, Building D, Room 265, 4000 Reservoir Road, NW, Washington DC 20057, USA.
Neuroscience. 2021 Apr 15;460:161-166. doi: 10.1016/j.neuroscience.2021.02.004. Epub 2021 Feb 10.
Ubiquitin Specific Protease (USP)-13 is a de-ubiquitinase member of the cysteine-dependent protease superfamily that cleaves ubiquitin off protein substrates to reverse ubiquitin-mediated protein degradation. Several findings implicate USPs in neurodegeneration. Ubiquitin targets proteins to major degradation pathways, including the proteasome and the lysosome. In melanoma cells, USP13 regulates the degradation of several proteins primarily via ubiquitination and de-ubiquitination. However, the significance of USP13 in regulating protein clearance in neurodegeneration is largely unknown. This mini-review summarizes the most recent evidence pertaining to the role of USP13 in protein clearance via autophagy and the proteasome in neurodegenerative diseases.
泛素特异性蛋白酶(USP)-13是半胱氨酸依赖性蛋白酶超家族的一种去泛素化酶成员,它从蛋白质底物上切割下泛素,以逆转泛素介导的蛋白质降解。多项研究结果表明泛素特异性蛋白酶与神经退行性变有关。泛素将蛋白质靶向主要的降解途径,包括蛋白酶体和溶酶体。在黑色素瘤细胞中,USP13主要通过泛素化和去泛素化调节多种蛋白质的降解。然而,USP13在神经退行性变中调节蛋白质清除的重要性在很大程度上尚不清楚。这篇小型综述总结了关于USP13在神经退行性疾病中通过自噬和蛋白酶体进行蛋白质清除作用的最新证据。